Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Shanghai Kaibao Pharmaceutical (300039)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
6.16 +0.05    +0.82%
30/04 - Closed. Currency in CNY ( Disclaimer )
Type:  Equity
Market:  China
ISIN:  CNE100000JZ3 
  • Volume: 17,276,722
  • Bid/Ask: 6.16 / 6.16
  • Day's Range: 6.09 - 6.22
Shanghai Kaibao Pharmaceutical 6.16 +0.05 +0.82%

300039 Balance Sheet

 
Featured here, the Balance Sheet for Shanghai Kaibao Pharmaceutical, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 1680.26 1474.88 1505.59 1470.94
Cash and Short Term Investments 918.49 751.95 731.98 615.64
Cash - - - -
Cash & Equivalents 799.69 601.94 571.46 582.75
Short Term Investments - - - -
Total Receivables, Net 578.77 529.74 566.5 662.94
Accounts Receivables - Trade, Net 566.23 529.32 509.51 633.63
Total Inventory 159.19 171.79 165.98 152.37
Prepaid Expenses - - - -
Other Current Assets, Total 23.81 21.4 41.13 39.99
Total Assets 4286.99 4579.67 4402.54 4529.99
Property/Plant/Equipment, Total - Net 283.39 290.09 294.75 301.59
Property/Plant/Equipment, Total - Gross - - - 820.02
Accumulated Depreciation, Total - - - -518.43
Goodwill, Net - - 9.04 9.04
Intangibles, Net 44.39 45.11 44.1 44.93
Long Term Investments 907.98 1309.7 1224.12 1376.83
Note Receivable - Long Term 12.54 0.414 56.99 29.31
Other Long Term Assets, Total 1338.07 1428.07 1308.96 1308.23
Other Assets, Total -244.09 -154.71 -182.88 -419.27
Total Current Liabilities 357.39 334.85 385.66 428.7
Accounts Payable 197.23 134.85 114.38 182
Payable/Accrued - - - -
Accrued Expenses 1.04 1.96 4.12 89.99
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 159.12 198.04 267.16 156.71
Total Liabilities 507.29 546.82 580.67 639.07
Total Long Term Debt - - - -
Long Term Debt - - - -
Capital Lease Obligations - - - -
Deferred Income Tax 108.45 168.71 149.7 172.65
Minority Interest 1.48 1.64 0.319 0.403
Other Liabilities, Total 39.98 41.62 44.99 37.31
Total Equity 3779.7 4032.86 3821.87 3890.92
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 1046 1046 1046 1046
Additional Paid-In Capital 8.62 8.62 8.62 8.62
Retained Earnings (Accumulated Deficit) 2138.72 2050.26 1918.51 1857.68
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 586.35 927.97 848.73 978.62
Total Liabilities & Shareholders' Equity 4286.99 4579.67 4402.54 4529.99
Total Common Shares Outstanding - - - -
Total Preferred Shares Outstanding - - - -
* In Millions of CNY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

300039 Comments

Write your thoughts about Shanghai Kaibao Pharmaceutical
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email